NCT03383783 - Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions

Caries

Interventions

DRUG

0 ppm F (placebo, negative control)

Each subject will use this product during one of the four treatment periods in the crossover study design.

DRUG

250 ppm F as NaF (dose-response control)

Each subject will use this product during one of the four treatment periods in the crossover study design.

DRUG

500 ppm F as NaF (dose-response control)

Each subject will use this product during one of the four treatment periods in the crossover study design.

DRUG

1100 ppm F as NaF (positive control)

Each subject will use this product during one of the four treatment periods in the crossover study design.

Trial Locations (1)

Indiana University School of Dentistry, Oral Health Research Institute, Indianapolis